Even if excess health spending, the gap between health spending and income growth, were cut in half, a very large share of income growth would still be devoted to healthcare
At current spending growth, a large share of increase in wealth over time will be absorbed by healthcare-44% between 2007 and 2020, according to new analysis from Health Affairs.
Even if excess health spending-the gap between health spending and income growth-were cut in half, a very large share of income growth will be devoted to healthcare (31%), according to Michael E. Chernew, PhD, Harvard Medical School Department of Health Care Policy, Boston.
“Over longer periods the estimates are more dramatic-63% between 2050 and 2083 in the best case,” Chernew says. “This is important because it illustrates that the status quo cannot continue. No matter what else managed care executives do, if they cannot solve the spending growth problem, some possibly drastic solution will be needed.”
Chernew suggests that some combination of payment reform and benefit design will be needed. For example, he points to Blue Cross Blue Shield of Massachusetts Inc.’s (BCBSMA) Alternative Quality Contract (AQC). First offered in 2008, the AQC pays doctors and hospitals based on the quality and outcome of the care they provide to patients. The AQC is designed to improve the quality of care members receive and cut current annual medical cost trends in half.
“The AQC offered by BCBSMA is a possibility, but we will continually have to experiment and face these challenges,” Chernew says.
Although no company wants to explain to its consumers why its product is costly, Shawn Jenkins, president and CEO of Benefitfocus, believes it is essential to educate members about premium cost-drivers.
“Explain to members how their lifestyle-diet, exercise, etc.-will result in additional needs for healthcare services or not,” Jenkins says. “Making that financial connection and providing them with wellness tools to manage their lifestyle can incent members to the right behavior.”
Finally, says Jenkins, executives must get creative in product design-such as rewards for positive behavior-to the extent the member anticipates and helps control the cost drivers.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More